{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:13:38Z","timestamp":1792725218570,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA060553"],"award-info":[{"award-number":["P30-CA060553"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30AR057216"],"award-info":[{"award-number":["P30AR057216"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003185","name":"National Psoriasis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003185","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jid.2019.06.146","type":"journal-article","created":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T01:35:45Z","timestamp":1565832945000},"page":"435-444.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Targeting the IL-17 Receptor Using Liposomal Spherical Nucleic Acids as Topical Therapy for Psoriasis"],"prefix":"10.1016","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3190-5422","authenticated-orcid":false,"given":"Haoming","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7088-5129","authenticated-orcid":false,"given":"Richard S.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7482-4454","authenticated-orcid":false,"given":"Katherine","family":"Bagnowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9197-1878","authenticated-orcid":false,"given":"Jeong Min","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7585-8333","authenticated-orcid":false,"given":"Sara","family":"Radecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2235-5630","authenticated-orcid":false,"given":"Weston L.","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8471-1381","authenticated-orcid":false,"given":"Bart R.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4664-3058","authenticated-orcid":false,"given":"Subbarao","family":"Nallagatla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2976-8326","authenticated-orcid":false,"given":"Andrew","family":"Schook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1804-7873","authenticated-orcid":false,"given":"Rishika","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0996-0548","authenticated-orcid":false,"given":"David A.","family":"Giljohann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6187-6549","authenticated-orcid":false,"given":"Amy S.","family":"Paller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2019.06.146_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/bs.mie.2015.07.015","article-title":"In\u00a0vitro model of the epidermis: connecting protein function to 3d structure","volume":"569","author":"Arnette","year":"2016","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.jid.2019.06.146_bib2","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","article-title":"IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes","volume":"174","author":"Boniface","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2019.06.146_bib3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/jid.2010.340","article-title":"Integrative responses to IL-17 and TNF-alpha in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2019.06.146_bib4","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","volume":"129","author":"Di Cesare","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2019.06.146_bib5","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1182\/blood.V80.11.2721.2721","article-title":"Interleukin-4 (IL-4) receptor expression on human T cells is affected by different intracellular signaling pathways and by IL-4 at transcriptional and posttranscriptional level","volume":"80","author":"Dokter","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.jid.2019.06.146_bib6","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1002\/eji.201343801","article-title":"TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis","volume":"43","author":"Flutter","year":"2013","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jid.2019.06.146_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1432-1033.1994.tb18991.x","article-title":"Biosynthesis and half-life of the interleukin-6 receptor and its signal transducer gp130","volume":"223","author":"Gerhartz","year":"1994","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jid.2019.06.146_bib9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2133.2012.11099.x","article-title":"Psoriasis: rationale for targeting interleukin-17","volume":"167","author":"Girolomoni","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2019.06.146_bib32","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/jid.2012.391","article-title":"Alteration of the EphA2\/Ephrin-A signaling axis in psoriatic epidermis","volume":"133","author":"Gordon","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2019.06.146_bib10","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","volume":"2","author":"Greb","year":"2016","journal-title":"Psoriasis. Nat Rev Dis Primers"},{"key":"10.1016\/j.jid.2019.06.146_bib11","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jid.2016.10.024","article-title":"The snowballing literature on imiquimod-induced skin inflammation in mice: a critical appraisal","volume":"137","author":"Hawkes","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2019.06.146_bib12","doi-asserted-by":"crossref","first-page":"52ra72","DOI":"10.1126\/scitranslmed.3001107","article-title":"Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis","volume":"2","author":"Hueber","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2019.06.146_bib13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/pde.13422","article-title":"Use of topical therapies for pediatric psoriasis: A systematic review","volume":"35","author":"Kravvas","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jid.2019.06.146_bib14","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jid.2017.07.851","article-title":"RNA aptamer delivery through intact human skin","volume":"138","author":"Lenn","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2019.06.146_bib15","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","article-title":"Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis","volume":"366","author":"Leonardi","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2019.06.146_bib16","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.jid.2017.04.027","article-title":"Topically delivered tumor necrosis factor-alpha-targeted gene regulation for psoriasis","volume":"137","author":"Lewandowski","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2019.06.146_bib18","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1021\/mp900172m","article-title":"Regulating immune response using polyvalent nucleic acid-gold nanoparticle conjugates","volume":"6","author":"Massich","year":"2009","journal-title":"Mol Pharm"},{"key":"10.1016\/j.jid.2019.06.146_bib19","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jid.2019.01.006","article-title":"Imiquimod-induced psoriasis in mice depends on the IL-17 signaling of keratinocytes","volume":"139","author":"Moos","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2019.06.146_bib20","first-page":"115","article-title":"Cytokine kinetics in an in\u00a0vitro whole blood model following an endotoxin challenge","volume":"12","author":"Oliver","year":"1993","journal-title":"Lymphokine Cytokine Res"},{"key":"10.1016\/j.jid.2019.06.146_bib21","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJMoa1109017","article-title":"Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis","volume":"366","author":"Papp","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2019.06.146_bib22","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1038\/jid.2012.163","article-title":"Anti-IL-17 receptor antibody AMG 827 leads to rapid clinical response in subjects\u00a0with moderate to severe psoriasis: results from a phase I, randomized, placebo-controlled trial","volume":"132","author":"Papp","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2019.06.146_bib23","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1002\/eji.201445215","article-title":"IMQ-induced skin inflammation in mice is dependent on IL-1R1 and MyD88 signaling but independent of the NLRP3 inflammasome","volume":"45","author":"Rabeony","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jid.2019.06.146_bib24","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1073\/pnas.1505951112","article-title":"siRNA-based spherical nucleic acids reverse impaired wound healing in diabetic mice by ganglioside GM3 synthase knockdown","volume":"112","author":"Randeria","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2019.06.146_bib25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1021\/nl802958f","article-title":"Polyvalent DNA nanoparticle conjugates stabilize nucleic acids","volume":"9","author":"Seferos","year":"2009","journal-title":"Nano Lett"},{"key":"10.1016\/j.jid.2019.06.146_bib26","doi-asserted-by":"crossref","first-page":"e0147979","DOI":"10.1371\/journal.pone.0147979","article-title":"Development of a topical treatment for psoriasis targeting ROR\u03b3: from bench to skin","volume":"11","author":"Smith","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jid.2019.06.146_bib27","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2019.06.146_bib28","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/jid.2013.532","article-title":"Ganglioside GM3 depletion reverses impaired wound healing in diabetic mice by activating IGF-1 and insulin receptors","volume":"134","author":"Wang","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2019.06.146_bib29","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/eji.200535503","article-title":"IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis","volume":"36","author":"Wolk","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jid.2019.06.146_bib30","first-page":"1180","article-title":"Pharmacokinetics of tumor necrosis factor alpha after intravenous administration in rats. Dose dependence and influence of tumor necrosis factor beta","volume":"39","author":"Zahn","year":"1989","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.jid.2019.06.146_bib31","doi-asserted-by":"crossref","first-page":"11975","DOI":"10.1073\/pnas.1118425109","article-title":"Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation","volume":"109","author":"Zheng","year":"2012","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X19326910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X19326910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:44:14Z","timestamp":1762206254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X19326910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0022202X19326910"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2019.06.146","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the IL-17 Receptor Using Liposomal Spherical Nucleic Acids as Topical Therapy for Psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2019.06.146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}